Selected article for: "age group and high score"

Author: Marincu, Iosif; Bratosin, Felix; Vidican, Iulia; Bostanaru, Andra-Cristina; Frent, Stefan; Cerbu, Bianca; Turaiche, Mirela; Tirnea, Livius; Timircan, Madalina
Title: Predictive Value of Comorbid Conditions for COVID-19 Mortality
  • Cord-id: uv6bm0id
  • Document date: 2021_6_16
  • ID: uv6bm0id
    Snippet: In this paper, we aim at understanding the broad spectrum of factors influencing the survival of infected patients and the correlations between these factors to create a predictive probabilistic score for surviving the COVID-19 disease. Initially, 510 hospital admissions were counted in the study, out of which 310 patients did not survive. A prediction model was developed based on this data by using a Bayesian approach. Following the data collection process for the development study, the second
    Document: In this paper, we aim at understanding the broad spectrum of factors influencing the survival of infected patients and the correlations between these factors to create a predictive probabilistic score for surviving the COVID-19 disease. Initially, 510 hospital admissions were counted in the study, out of which 310 patients did not survive. A prediction model was developed based on this data by using a Bayesian approach. Following the data collection process for the development study, the second cohort of patients totaling 541 was built to validate the risk matrix previously created. The final model has an area under the curve of 0.773 and predicts the mortality risk of SARS-CoV-2 infection based on nine disease groups while considering the gender and age of the patient as distinct risk groups. To ease medical workers’ assessment of patients, we created a visual risk matrix based on a probabilistic model, ranging from a score of 1 (very low mortality risk) to 5 (very high mortality risk). Each score comprises a correlation between existing comorbid conditions, the number of comorbid conditions, gender, and age group category. This clinical model can be generalized in a hospital context and can be used to identify patients at high risk for whom immediate intervention might be required.

    Search related documents:
    Co phrase search for related documents
    • liver disease and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • liver disease and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • liver disease and low mortality risk: 1
    • liver disease and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • liver disease and lupus erythematosus: 1, 2, 3, 4, 5, 6
    • logistic regression model and lopinavir ritonavir: 1, 2, 3, 4, 5, 6
    • logistic regression model and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • logistic regression model and low mortality risk: 1
    • logistic regression model and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • logistic regression model and lupus erythematosus: 1, 2, 3
    • lopinavir ritonavir and low mortality: 1, 2, 3, 4, 5, 6, 7, 8
    • lopinavir ritonavir and low mortality risk: 1
    • lopinavir ritonavir and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • lopinavir ritonavir and lupus erythematosus: 1, 2, 3, 4
    • low mortality and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • low mortality and lupus erythematosus: 1
    • low mortality risk and lung disease: 1, 2
    • lung disease and lupus erythematosus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18